From: "Ronny Ramey" <jaizbrzjirbjk@list.ru>
To: <paliourg@iit.demokritos.gr>
Subject:  HEALTH CARE SECTOR: NEWS On Tubercin and FDA Testing--Paliourg 01358244
Date: Fri, 13 Feb 2004 06:43:37 +0300
MIME-Version: 1.0
Content-Type: text/html;
	charset="iso-8859-7"
Content-Transfer-Encoding: quoted-printable
X-Priority: 3
X-MSMail-Priority: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2527

<p><span class=3D"heading1black">Business Wire---Hard to Treat Diseases=20
Incorporated - HTDS - Announces: Meeting with T-19 Manufacturer and =
Tubercin FDA=20
Testing</span></p>
<p><span class=3D"normal">Hard to Treat Diseases Incorporated (Pink =
Sheets: HTDS)=20
announces that consultants of the Company are meeting with a P-3=20
manufacturer and an FDA testing group this week. It is expected that a =
decision=20
will be made sometime this month regarding the most expeditious manner =
to safely=20
make available T-19(R) to the people who need it. </p>
<p>HTDS consultants are also meeting with representatives of a=20
prestigious FDA approved testing facility located at a major US =
University to=20
discuss the protocols, procedures, budgets and cost estimates for =
additional=20
testing. The testing results to date have been provided by Dr. Richard =
Ishmael,=20
M.D. of The Natcel, Dev. and Cancer Treatment Center of Oklahoma and Dr. =
Wei R.=20
Chen, Ph.D. of The University of Oklahoma. Such results are currently =
being=20
reviewed by the Company's Scientific Advisory Panel.</p>
<p>HTDS consultants are also meeting with an FDA approved P-3=20
manufacturer regarding T-19(R). A P-3 manufacturer is capable of =
producing a=20
product under extreme conditions. Tubercin(R) and the related T-19(R) =
are=20
produced from live Tuberculosis cells under extremely stringent =
conditions.=20
Depending on the approval process required by the testing facility and =
the=20
opinion of the Company's Scientific Advisory Panel, the delivery system =
for the=20
T-19 will either be a nasal spray or an inhaler. </p>
<p>&quot;The holistic market for T-19(R) as an immunostimulant has =
phenomenal=20
potential,&quot; stated the President and CEO of HTDS, Mr. Colm J. King. =
&quot;We intend=20
to get T-19(R) on the market as fast as possible. Additionally, the =
Company=20
hopes to meet all criteria so that it may qualify Tubercin(R) for fast =
track=20
treatment and thereby deliver it to patients in the near future. Results =
of the=20
above meetings among the consultants will be released when =
available.&quot; </p>
<p><font size=3D"1">Statements in this press release that are not =
historical facts=20
are forward-looking statements within the meaning of the Securities Act =
of 1933,=20
as amended. Those statements include statements regarding the intent, =
belief or=20
current expectations of the Company and its management. Such statements =
reflect=20
management's current views, are based on certain assumptions and involve =
risks=20
and uncertainties. Actual results, events, or performance may differ =
materially=20
from the above forward-looking statements due to a number of important =
factors,=20
and will be dependent upon a variety of factors, including, but not =
limited to,=20
our ability to obtain additional financing and access funds from our =
existing=20
financing arrangements that will allow us to continue our current and =
future=20
operations and whether demand for our product and testing service in =
domestic=20
and international markets will continue to expand. The Company =
undertakes no=20
ob.ligation to publicly update these forward-looking statements to =
reflect=20
events or circumstances that occur after the date hereof or to reflect =
any=20
change in the Company's expectations with regard to these =
forward-looking=20
statements or the occurrence of unanticipated events. </font></span></p>
<p>blunt headwall cheese barbital guise gauze lazarus log salad =
reformatory conch inviolable reluctant  martha pontific despicable =
roughshod emphysema discoid bong christoffel baseboard ally access =
interferometer criss farmington southeastern bosom wallboard hailstorm =
crania chippendale carbuncle angela bespeak claret aile sax whiplash =
thyronine  pasteup naked resort comport fell girlie quadrennial somewhat =
utterance erudition assay paraboloid discus cumulate spiny salt =
proverbial millionth heater patient schoolgirlish  certitude artifice =
braniff aforesaid stableman byzantine fuzzy cornstarch maraud neolithic =
schooner abridge cloddish cyanamid quartet admiralty trenchant crimea =
reagan exeter cloak medford </p>
